We are live on ! Find out more
LVACW

LAVA Medtech Acquisition Corp. Warrants
LVACW

Delisted

LVACW was delisted on the 12th of May, 2023.

Back to rankings

33 hedge funds and large institutions have $487K invested in LAVA Medtech Acquisition Corp. Warrants in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 → 33 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

44% less capital invested

Capital invested by funds: $867K → $487K (-$380K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
33
Holders Change
–
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
4
Closed
3
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$2.75K
2
SCM
Shaolin Capital Management
Florida
+$1.84K
3
GAM
Gritstone Asset Management
Maryland
+$1.04K
4
UBS Group
UBS Group
Switzerland
+$32
5
CS
Clear Street
New York
+$27

Top Sellers

Rank Fund Capital Flow
1
SG
StoneX Group
New York
-$3.14K
2
CH
CVI Holdings
Delaware
-$236
3
AA
AQR Arbitrage
Connecticut
-$51
4
SC
Sculptor Capital
New York
-$46
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$130K – – –
PC
2
Periscope Capital
Ontario, Canada
$47.2K – – –
SCM
3
Saba Capital Management
New York
$41.2K – – –
EFI
4
EHP Funds Inc
Canada
$33.1K – – –
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$28K – – –
CCA
6
Castle Creek Arbitrage
Colorado
$22.5K – – –
SCM
7
Shaolin Capital Management
Florida
$21K +$1.84K +33,700 +13%
FBCM
8
Fort Baker Capital Management
California
$20.5K – – –
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$15.9K – – –
SC
10
Sculptor Capital
New York
$15.6K -$46 -850 -0.5%
PMAM
11
Picton Mahoney Asset Management
Ontario, Canada
$15K – – –
LA
12
Linden Advisors
New York
$10.6K – – –
GAM
13
Gritstone Asset Management
Maryland
$10.1K +$1.04K +19,017 +17%
TCM
14
Tenor Capital Management
New York
$9.38K – – –
CSS
15
Cubist Systematic Strategies
Connecticut
$9.07K – – –
Goldman Sachs
16
Goldman Sachs
New York
$7.08K – – –
SSA
17
Schonfeld Strategic Advisors
New York
$6.28K – – –
WAM
18
Wolverine Asset Management
Illinois
$6.2K – – –
CH
19
CVI Holdings
Delaware
$6.14K -$236 -4,313 -5%
RCM
20
Radcliffe Capital Management
Pennsylvania
$5.84K – – –
AA
21
AQR Arbitrage
Connecticut
$5.63K -$51 -927 -1%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$5.19K – – –
CAC
23
Cowen and Company
New York
$3.77K +$2.75K +50,300 New
Walleye Capital
24
Walleye Capital
New York
$2.6K – – –
SAMU
25
SONA Asset Management (US)
New York
$2.25K – – –
1
2

LVACW Hedge Fund Activity: Q1 2023 in Review

33 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q1 2023, worth a combined $487K — down 44% from $867K a quarter earlier.

Fund positioning in LVACW was balanced in Q1 2023: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 4 trimmed.

The largest buyer was Cowen and Company, opening a new position worth an estimated $2.75K. The largest seller was StoneX Group, cutting an estimated $3.14K.

  • 33 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $487K of LAVA Medtech Acquisition Corp. Warrants stock for Q1 2023, down 44% quarter-over-quarter.
  • 3 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q1 2023 and 3 closed out, a net change of 0 holders.
  • The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q1 2023 was Cowen and Company, an estimated $2.75K added.
  • The largest LAVA Medtech Acquisition Corp. Warrants seller in Q1 2023 was StoneX Group, an estimated $3.14K sold.

Based on aggregated 13F filings for Q1 2023.